Advertisement

Picture EBD Group World of Partnering Opportunities 650x100px
Person › Details

Adesh Kaul (Basilea Pharmaceutica Ltd. (SIX: BSLN))

Kaul, Adesh (Basilea 201803– Chief Corp Dev Officer before Polyphor + Basilea + Genedata + Neue Züricher Bank)

 

Organisations Organisation Basilea Pharmaceutica Ltd. (SIX: BSLN)
  Group Basilea (Group)
  Former/major organisation Polyphor Ltd. (SIX: POLN)
  Today Spexis AG (SIX: SPEX)
  Group Spexis (Group)
Products Product antibiotic
  Product 2 anti-infective drug
     

   
Record changed: 2024-04-07

Advertisement

Picture Berlin Partner Voices Martin Rahmel TU Berlin GreenChem 650x200px


More documents for Adesh Kaul


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top